Brief: Immunovia Q1 Operating Loss At SEK 18.4 Mln
May 7 (Reuters) - Immunovia AB (publ) IMMNOV.ST: IMMUNOVIA Q1 ADJUSTED EPS SEK -0.03 Q1 2026 NET SALES 374 KSEK; OPERATING LOSS 18.4 MSEK; EPS -0.03 SEK BOARD WITHDRAWS PROPOSAL FOR REVERSE SHARE SPLIT Source text: ID:nMFN36Y7Fl Further company coverage: IMMNOV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study